Cervical cancer cells demonstrated elevated levels of Bcl-2 anti-apoptotic protein [46] as well as a reduced wild-type p53 expression due to degradation by HPV E6-associated protein [47], a signature that promotes increased resistance to chemotherapy. This evidence concerns the gene BCL2 and cervical cancer.